StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
384
This month
5
This year
38
Publishing Date
2024 - 02 - 15
3
2024 - 02 - 06
3
2023 - 11 - 14
3
2023 - 11 - 09
4
2023 - 11 - 08
3
2023 - 11 - 07
4
2023 - 11 - 02
3
2023 - 08 - 10
4
2023 - 08 - 08
4
2023 - 08 - 03
4
2023 - 05 - 11
6
2023 - 05 - 09
3
2023 - 05 - 08
3
2023 - 05 - 04
3
2022 - 11 - 10
4
2022 - 11 - 07
2
2022 - 11 - 03
2
2022 - 11 - 02
2
2022 - 10 - 26
2
2022 - 08 - 15
3
2022 - 08 - 11
2
2022 - 08 - 09
2
2022 - 07 - 27
3
2022 - 06 - 21
3
2022 - 06 - 01
2
2022 - 05 - 13
2
2022 - 05 - 10
5
2022 - 05 - 03
3
2022 - 03 - 24
2
2022 - 03 - 15
2
2022 - 03 - 03
2
2022 - 02 - 17
3
2021 - 12 - 10
2
2021 - 11 - 15
2
2021 - 11 - 12
3
2021 - 11 - 10
5
2021 - 11 - 03
2
2021 - 08 - 16
3
2021 - 08 - 12
2
2021 - 08 - 11
2
2021 - 08 - 06
2
2021 - 08 - 05
7
2021 - 08 - 04
3
2021 - 07 - 22
2
2021 - 05 - 17
2
2021 - 05 - 14
3
2021 - 05 - 13
2
2021 - 05 - 12
4
2021 - 05 - 11
2
2021 - 05 - 06
3
2021 - 05 - 03
2
2021 - 04 - 28
2
2021 - 03 - 25
3
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 09
2
2021 - 03 - 02
2
2021 - 02 - 25
3
2021 - 02 - 18
2
2021 - 01 - 06
2
Sector
Communications
3
Consumer non-durables
2
Finance
6
Finance and insurance
3
Health services
1
Health technology
363
Manufacturing
4
N/a
10
Process industries
3
Producer manufacturing
3
Professional, scientific, and technical services
1
Technology services
1
Tags
America
194
Automotive
239
Bioscience
209
Biotech-bay
294
Biotech-beach
255
Business
1225
China
198
Conference
659
Corporation
802
Covid
341
Covid-19
340
Diagnostics
206
Drug
196
Earnings
2052
Energy
664
Esg
223
Europe
223
Events
258
Financial
7718
Financial results
4356
First
315
Food
249
Genetown
239
Global
4119
Grant
403
Granted
241
Grants
490
Group
697
Growing
470
Growth
2520
Health
404
Impact
242
Iot
261
Management
313
Market
6717
Medical
245
N/a
36884
Nasdaq
810
Pharm-country
251
Pharma
384
Pharmaceuticals
558
Positive
353
Program
385
Reach
366
Report
15972
Research
1587
Results
21247
Sales
453
Services
358
Smart
250
Software
224
Solutions
243
System
259
Technology
594
Therapeutics
1465
Treatment
248
Trends
240
Trial
432
Update
1730
Year
3457
Entities
180 life sciences corp.
1
3m company
2
Abbott laboratories
5
Abbvie inc.
2
Acasti pharma, inc.
9
Affimed n.v.
1
Agilent technologies, inc.
2
Amcor plc
1
American international group, inc.
1
Amgen inc.
1
Antares pharma, inc.
8
Arma services inc
2
Ascendis pharma a/s
12
Astellas pharma inc
2
Athira pharma, inc.
11
Atyr pharma, inc.
4
Becton, dickinson and company
3
Bio-rad laboratories, inc.
3
Bnp paribas
3
Bridgebio pharma, inc.
49
Bristol-myers squibb company
2
Chemocentryx, inc.
2
China pharma holdings, inc.
4
Cocrystal pharma, inc.
15
Eli lilly and company
2
Esab corp
2
Essa pharma inc.
11
Evoke pharma, inc.
15
Eyegate pharmaceuticals, inc.
3
Forward pharma a/s
2
Fsd pharma inc.
2
Gilead sciences, inc.
5
Hercules capital, inc.
3
Hookipa pharma inc.
17
Innate pharma s.a.
18
Innate pharma sa
14
Inozyme pharma, inc.
22
Johnson & johnson
10
Kering
2
Lantern pharma inc.
13
Lumos pharma, inc.
18
Mei pharma, inc.
11
Newamsterdam pharma co b.v.
5
Novartis ag
5
Novo nordisk a/s
12
Ocuphire pharma inc.
7
Orange
3
Oyster point pharma, inc.
7
Plx pharma inc.
13
Prime number acquisition i corp.
2
Quantum fintech acquisition corp
2
Royalty pharma plc
7
Sanofi
28
Teva pharmaceutical industries ltd
2
Thermo fisher scientific inc
4
Urogen pharma ltd.
21
Verona pharma plc
29
Viatris inc.
2
Vincera pharma inc
9
Zosano pharma corporation
6
Symbols
A
2
ABBV
2
ABT
5
ACST
9
ALPMF
2
ALPMY
2
ARMV
2
ASND
12
ATHA
11
ATRS
8
BBIO
49
BDX
3
BIO
3
BMY
2
BNPQF
3
BNPQY
3
CCXI
2
COCP
15
CPHI
4
EPIX
11
ESAB
2
EVOK
15
EYEG
3
FNCTF
3
FWP
2
GILD
5
HOOK
17
HTGC
3
HUGE
2
INZY
22
IPHA
18
IPHYF
14
JNJ
10
LIFE
4
LLY
2
LTRN
13
LUMO
18
MEIP
11
MMM
2
NAMS
5
NVO
12
NVS
5
NVSEF
5
OCUP
7
OYST
7
PLXP
13
PNAC
2
PPRUF
2
PPRUY
2
QFTA
2
RPRX
7
SNY
28
SNYNF
21
TEVJF
2
TMO
4
URGN
21
VINC
9
VRNA
29
VTRS
2
ZSAN
6
Exchanges
Amex
5
Nasdaq
369
Nyse
45
Crawled Date
2024 - 02 - 15
3
2024 - 02 - 06
3
2023 - 11 - 14
3
2023 - 11 - 09
3
2023 - 11 - 08
3
2023 - 11 - 07
4
2023 - 11 - 02
3
2023 - 08 - 10
4
2023 - 08 - 08
4
2023 - 08 - 03
4
2023 - 05 - 11
5
2023 - 05 - 09
3
2023 - 05 - 08
3
2023 - 05 - 04
3
2022 - 11 - 10
4
2022 - 11 - 02
2
2022 - 10 - 26
2
2022 - 09 - 09
2
2022 - 08 - 16
2
2022 - 08 - 15
2
2022 - 08 - 09
2
2022 - 08 - 03
2
2022 - 07 - 27
3
2022 - 06 - 21
3
2022 - 06 - 01
2
2022 - 05 - 10
5
2022 - 05 - 03
3
2022 - 03 - 24
2
2022 - 03 - 15
2
2022 - 03 - 03
2
2022 - 02 - 17
3
2021 - 12 - 10
2
2021 - 11 - 20
2
2021 - 11 - 15
2
2021 - 11 - 12
3
2021 - 11 - 10
4
2021 - 11 - 03
2
2021 - 08 - 16
3
2021 - 08 - 12
2
2021 - 08 - 11
2
2021 - 08 - 06
2
2021 - 08 - 05
8
2021 - 08 - 04
2
2021 - 07 - 22
2
2021 - 05 - 17
2
2021 - 05 - 14
3
2021 - 05 - 13
2
2021 - 05 - 12
3
2021 - 05 - 11
2
2021 - 05 - 06
3
2021 - 05 - 03
2
2021 - 04 - 28
2
2021 - 03 - 25
3
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 09
2
2021 - 03 - 02
2
2021 - 02 - 25
2
2021 - 02 - 18
2
2021 - 02 - 03
3
Crawled Time
00:00
12
00:12
1
00:20
1
01:00
3
03:00
1
05:00
1
06:00
8
07:00
17
07:03
2
08:00
11
09:00
6
10:00
5
10:41
1
11:00
24
12:00
49
12:02
1
12:04
1
12:15
5
12:20
9
12:30
10
13:00
44
13:01
1
13:15
5
13:20
4
13:30
9
14:00
20
14:15
1
14:20
4
14:30
1
15:00
8
15:15
1
16:00
4
16:20
4
17:00
9
18:00
2
18:58
1
19:00
4
20:00
20
21:00
33
21:03
1
21:11
1
22:00
27
23:00
11
23:03
1
Source
bridgebio.com
5
ir.plxpharma.com
5
ir.zosanopharma.com
4
spacfeed.com
2
www.athira.com
4
www.biospace.com
150
www.fsdpharma.com
1
www.globenewswire.com
172
www.jupiterwellnessinc.com
1
www.prnewswire.com
40
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
report
tags :
Pharma
save search
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
Published:
2024-04-11
(Crawled : 21:00)
- biospace.com/
MEIP
|
$3.38
2.11%
2.07%
12K
|
Health Technology
|
-11.97%
|
O:
0.27%
H:
1.71%
C:
-3.71%
me-344
avastin
pharma
cancer
study
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 10, 2024
Published:
2024-04-10
(Crawled : 12:00)
- biospace.com/
BBIO
|
$24.98
0.0%
2M
|
Health Technology
|
-12.33%
|
O:
-4.11%
H:
0.81%
C:
0.15%
pharma
nasdaq
grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-04-10
(Crawled : 12:00)
- bridgebio.com
BBIO
|
$24.98
0.0%
2M
|
Health Technology
|
-12.33%
|
O:
-4.11%
H:
0.81%
C:
0.15%
pharma
nasdaq
grants
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-04-05
(Crawled : 22:00)
- globenewswire.com
INZY
|
$4.57
-1.72%
-1.75%
560K
|
Health Technology
|
Email alert
Add to watchlist
pharma
nasdaq
grants
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published:
2024-04-05
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-6.35%
|
O:
-3.44%
H:
0.0%
C:
0.0%
IPHA
|
$2.4
-0.42%
-0.42%
11K
|
Health Technology
|
-6.0%
|
O:
-0.4%
H:
0.0%
C:
-5.22%
pharma
report
universal
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published:
2024-03-29
(Crawled : 20:00)
- globenewswire.com
VINC
|
$0.8967
-5.63%
-5.97%
530K
|
|
Email alert
Add to watchlist
pharma
year
update
financial
results
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Published:
2024-03-28
(Crawled : 12:00)
- globenewswire.com
COCP
|
$1.43
-1.39%
5.1K
|
Health Technology
|
0.67%
|
O:
2.68%
H:
13.73%
C:
-8.5%
pharma
antiviral
financial
results
MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia
Published:
2024-03-26
(Crawled : 19:00)
- biospace.com/
MEIP
|
$3.38
2.11%
2.07%
12K
|
Health Technology
|
-14.51%
|
O:
-1.08%
H:
1.9%
C:
0.78%
pharma
update
leukemia
study
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
Published:
2024-03-26
(Crawled : 12:30)
- globenewswire.com
INZY
|
$4.57
-1.72%
-1.75%
560K
|
Health Technology
|
-26.48%
|
O:
2.09%
H:
14.47%
C:
6.6%
inz-701
pharma
report
ongoing
trials
topline
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published:
2024-03-22
(Crawled : 11:00)
- globenewswire.com
HOOK
|
$0.7695
0.92%
0.91%
170K
|
Health Technology
|
4.96%
|
O:
3.58%
H:
0.0%
C:
-5.19%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-8.47%
|
O:
0.03%
H:
0.16%
C:
-0.68%
pharma
business
year
financial
results
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published:
2024-03-21
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-3.83%
|
O:
0.3%
H:
0.0%
C:
0.0%
IPHA
|
$2.4
-0.42%
-0.42%
11K
|
Health Technology
|
-6.0%
|
O:
-4.51%
H:
4.25%
C:
0.96%
pharma
business
year
update
financial
results
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 20, 2024
Published:
2024-03-20
(Crawled : 12:00)
- biospace.com/
BBIO
|
$24.98
0.0%
2M
|
Health Technology
|
-12.24%
|
O:
0.46%
H:
1.37%
C:
0.25%
pharma
nasdaq
grants
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-03-20
(Crawled : 12:00)
- bridgebio.com
BBIO
|
$24.98
0.0%
2M
|
Health Technology
|
-12.24%
|
O:
0.46%
H:
1.37%
C:
0.25%
pharma
nasdaq
grants
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 20:00)
- globenewswire.com
EVOK
|
$0.489
-10.93%
-12.27%
21K
|
Health Technology
|
-30.33%
|
O:
-4.68%
H:
5.88%
C:
-3.58%
pharma
year
financial
results
Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
Published:
2024-03-12
(Crawled : 12:30)
- globenewswire.com
INZY
|
$4.57
-1.72%
-1.75%
560K
|
Health Technology
|
-20.21%
|
O:
-0.7%
H:
1.75%
C:
0.35%
pharma
business
year
financial
results
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
LTRN
|
$5.87
-2.0%
-2.04%
110K
|
Health Technology
|
-27.57%
|
O:
-2.06%
H:
0.74%
C:
-21.98%
pharma
report
year
financial
results
Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
Published:
2024-03-07
(Crawled : 21:00)
- globenewswire.com
LUMO
|
News
|
$2.64
4.76%
4.55%
12K
|
Health Technology
|
-16.83%
|
O:
-1.65%
H:
4.03%
C:
2.01%
pharma
year
update
financial
results
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
Published:
2024-03-07
(Crawled : 21:00)
- globenewswire.com
EVOK
|
$0.489
-10.93%
-12.27%
21K
|
Health Technology
|
-32.37%
|
O:
1.29%
H:
2.27%
C:
-0.57%
pharma
report
year
results
UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024
Published:
2024-03-04
(Crawled : 13:30)
- biospace.com/
URGN
|
$14.32
0.56%
0.56%
320K
|
Health Technology
|
-19.36%
|
O:
0.73%
H:
4.08%
C:
2.91%
pharma
report
financial
results
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-02-29
(Crawled : 07:00)
- globenewswire.com
VRNA
|
$16.1
-1.83%
-1.86%
490K
|
Health Technology
|
-6.72%
|
O:
3.48%
H:
2.74%
C:
-3.58%
pharma
year
update
financial
results
← Previous
1
2
3
4
5
6
7
8
9
…
19
20
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.